Document is current
Any future updates will be listed below
-
Authors
Zhang, Shi-Jiao
Liu, Yang
Wei, Yong-qian
Ma, Xiang-yu
Wang, Ying-bin
-
Funding
Funding for this research was provided by:
the Gansu Provincial Natural Science Foundation (24JRRA1106)
the Gansu Provincial Natural Science Foundation (24JRRA1106)
the Gansu Provincial Natural Science Foundation (24JRRA1106)
the Gansu Provincial Natural Science Foundation (24JRRA1106)
the Gansu Provincial Natural Science Foundation (24JRRA1106)
the General Project of the Joint Research Fund of the Gansu Provincial Department of Science and Technology (25JRRA1277)
the General Project of the Joint Research Fund of the Gansu Provincial Department of Science and Technology (25JRRA1277)
the General Project of the Joint Research Fund of the Gansu Provincial Department of Science and Technology (25JRRA1277)
the General Project of the Joint Research Fund of the Gansu Provincial Department of Science and Technology (25JRRA1277)
the General Project of the Joint Research Fund of the Gansu Provincial Department of Science and Technology (25JRRA1277)
the Special Research Project for Innovative Drug Market Authorization Clinical Studies of the National Health Commission's Medical and Health Science and Technology Development Research Center (WKZX2024CX301208)
the Special Research Project for Innovative Drug Market Authorization Clinical Studies of the National Health Commission's Medical and Health Science and Technology Development Research Center (WKZX2024CX301208)
the Special Research Project for Innovative Drug Market Authorization Clinical Studies of the National Health Commission's Medical and Health Science and Technology Development Research Center (WKZX2024CX301208)
the Special Research Project for Innovative Drug Market Authorization Clinical Studies of the National Health Commission's Medical and Health Science and Technology Development Research Center (WKZX2024CX301208)
the Special Research Project for Innovative Drug Market Authorization Clinical Studies of the National Health Commission's Medical and Health Science and Technology Development Research Center (WKZX2024CX301208)
the “Cuiying Science and Technology Innovation” Program of the Second Hospital of Lanzhou University (CY2022-MS-A20)
the “Cuiying Science and Technology Innovation” Program of the Second Hospital of Lanzhou University (CY2022-MS-A20)
the “Cuiying Science and Technology Innovation” Program of the Second Hospital of Lanzhou University (CY2022-MS-A20)
the “Cuiying Science and Technology Innovation” Program of the Second Hospital of Lanzhou University (CY2022-MS-A20)
the “Cuiying Science and Technology Innovation” Program of the Second Hospital of Lanzhou University (CY2022-MS-A20)
- License Information
-
More Information
Article History
Received: 2 August 2025
Accepted: 20 February 2026
First Online: 7 March 2026
Declarations
:
: The study was approved by the Ethics Committee of the Second Clinical Medical College of Lanzhou University (2024 A-1215, approved on September 23, 2024) and registered with the China Clinical Trial Registry (ChiCTR2400091488, registered on October 29, 2024). It adhered to the principles outlined in the Declaration of Helsinki and the CONSORT 2010 guidelines. Informed consent was obtained from all enrolled patients regarding study enrollment, anonymized data collection, and publication. All participants signed a written informed consent before surgery.
: Not applicable.
: The authors declare no competing interests.
